New research this month shows that the experimental antiviral obeldesivir prevented up to 100% of deaths in monkeys infected ...

A day after getting exposed to the Ebola virus, ten monkeys then received an Obeldesivir pill daily for ten days, while three control monkeys received no treatment and died. The study found that ...

Ebola in Uganda is the latest in a trend of outbreaks of viral hemorrhagic fevers in the east African region. Tanzania declared an outbreak of the Ebola-like Marburg disease in January, and in ...

Similar to the more widely known Ebola hemorrhagic fever, MHF is characterized by systemic viral replication, immunosuppression and abnormal inflammatory responses. These pathological features of ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

Recognised examples of such diseases include Ebola, Lassa fever and Marburg virus ... Test results have ruled out similar hemorrhagic diseases such as Ebola and Marburg virus.

The country is presently battling its eighth Ebola outbreak, confirmed by the Ministry of Health in January, with two ...

Ebola, which is spread by contact with the bodily fluids of an infected person or contaminated materials, manifests as a deadly hemorrhagic fever. Symptoms include fever, vomiting, diarrhea, muscle ...

It is not clear what is behind the outbreak, with patients testing negative for hemorrhagic fevers like Ebola and Marburg virus. About half of the patients have tested positive for malaria ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window KAMPALA ...

A 4-year-old child became the second person to die of Ebola in Uganda, the World Health Organization said Saturday (March 1, 2025), in a setback for health officials who had hoped for a quick end ...